These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Watching the reimbursement dollars: program validation aims to control waste in Medicare and Medicaid. Nicholson D Forum (Wash); 1980 Aug; 4(3):18-21. PubMed ID: 6998849 [No Abstract] [Full Text] [Related]
6. 'Generic substitution' in New Jersey, 1979-87. Culkin TT; Mendell S Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782 [TBL] [Abstract][Full Text] [Related]
7. The association of insurance type with costs of dispensed drugs. Mott DA; Kreling DH Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015 [TBL] [Abstract][Full Text] [Related]
8. The nature and consequences of policies intended to contain costs in outpatient drug insurance programs. Reutzel TJ Clin Ther; 1993; 15(4):752-64. PubMed ID: 8221825 [TBL] [Abstract][Full Text] [Related]
9. Defense for physicians under attack. Gilchrist AG Pa Med; 1989 Jul; 92(7):28-30. PubMed ID: 2666913 [No Abstract] [Full Text] [Related]
11. Are mobile meals a service or disservice? Heyde DA Hosp Financ Manage; 1979 Aug; 33(8):10. PubMed ID: 10297517 [No Abstract] [Full Text] [Related]
12. These doctors forced Medicaid to shape up. Cassidy R Med Econ; 1980 Aug; 57(16):23, 26, 28 passim. PubMed ID: 10297921 [No Abstract] [Full Text] [Related]
13. Differences in the cost of antidepressants across state Medicaid programs. Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875 [TBL] [Abstract][Full Text] [Related]
14. HCFA program statistics: Medicare and Medicaid. Health Care Financ Rev; 1979; 1(1):112-9. PubMed ID: 10309051 [No Abstract] [Full Text] [Related]
15. FDA drug list: key to generic substitution. FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical reimbursement under the Medicare and Medicaid programs. Becker S Health Care Law Mon; 2001 Feb; ():15-25. PubMed ID: 11260930 [No Abstract] [Full Text] [Related]
18. Liability at issue as firms target drug costs. Kenkel PJ Mod Healthc; 1990 Aug; 20(34):41. PubMed ID: 10105826 [No Abstract] [Full Text] [Related]
19. Industry warily eyes new Medicare drug plan. Vastag B Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141 [No Abstract] [Full Text] [Related]
20. Should the practice of drug sampling be retained or eliminated? Hosp Formul; 1994 Nov; 29(11):780, 782. PubMed ID: 10138575 [No Abstract] [Full Text] [Related] [Next] [New Search]